Abstract
Hsp27 phosphorylation is associated with many pathways in glioma, such as tumor cell proliferation and apoptosis inhibition. The aim of this study is to examine the separate and mutual effects of BIRB796 and bortezomib on pHsp27 and to investigate their effects on the viability of U87MG glioma cells. At the same time, the effects of the agents on the p38MAPK enzyme and caspase 3, which plays a role in the mechanism of apoptosis, were also investigated. The cytotoxic effect of bortezomib and BIRB796 on U87MG cells was investigated by MTT method. Hsp27 and pHsp27 proteins expression levels were exhibited by Western Blot analysis. Also, we examined the effects of BIRB796 on p38MAPK (α, β) enzyme inhibition and caspase 3 activity. According to the MTT results, BIRB796 did not significantly reduce cell proliferation in a dose-dependent manner, but bortezomib significantly reduced it in a dose and time-dependent manner. In Western blot analyses, 5 nM bortezomib, and 100, 250, 500 nM BIRB796 concentrations that show neither a cytotoxic nor a proliferative effect on the cells were used as combined treatment. It was seen that 5 nM bortezomib treatment significantly induced pHsp27 (76%) and Hsp27 (48%) expression levels in the glioma cells. Also it was found that BIRB796 treatments significantly decreased the level of Hsp27 and pHsp27. The combined treatments significantly reduced pHsp27 expression level. Our results showed that all treatments also significantly increased caspase 3 activation. In addition, BIRB796 inhibited p38α and p38β activities depending on time, and this agent effect on p38α was stronger than p38β. All results indicate that BIRB796 and bortezomib have additive effects on cell viability and caspase 3. Also BIRB796 agent may be an effective therapeutic option in cancer cells by reducing cell resistance, apoptosis and pHsp27 expression in the treatment of brain cancer.
Similar content being viewed by others
REFERENCES
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P., Integrins, in Molecular Biology of the Cell, Garland Science, 2002, 4th ed.
Chatterjee, S. and Burns, T.F., Targeting heat shock proteins in cancer: a promising therapeutic approach, Int. J. Mol. Sci., 2017, vol. 18, no. 9, p. 1978. https://doi.org/10.3390/ijms18091978
Chauhan, D., Hideshima, T., and Anderson, K.C., A novel proteasome inhibitor NPI-0052 as an anticancer therapy, Br. J. Cancer, 2006, vol. 95, no. 8, pp. 961–965. https://doi.org/10.1038/sj.bjc.6603406
Cornford, P.A., Dodson, A.R., Parsons, K.F., Desmond, A.D., Woolfenden, A., et al., Heat shock protein expression independently predicts clinical outcome in prostate cancer, Cancer Res., 2000, vol. 60, no. 24, pp. 7099–7105.
Durmus, H., Mertoglu, E., Sticht, H., Ceylaner, S., Kulaksızoglu, I.B., et al., Episodic psychosis, ataxia, motor neuropathy with pyramidal signs (PAMP syndrome) caused by a novel mutation in ADPRHL2 (AHR3), Neurol. Sci., 2021, pp. 1–8. https://doi.org/10.1007/s10072-021-05100-w
Freshney, R.I., Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications, Wiley, 2015.
Ge, B., Gram, H., Di Padova, F., Huang, B., New, L., et al., MAPKK-independent activation of p38α mediated by TAB1-dependent autophosphorylation of p38α, Science, 2002, vol. 295, no. 5558, pp. 1291–1294. https://doi.org/10.1126/science.1067289
Gurgis, F.M., Ziaziaris, W., and Munoz, L., Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting, Mol. Pharmacol., 2014, vol. 85, pp. 345–356. https://doi.org/10.1124/mol.113.090365
Jerby-Arnon, L., Shah, P., Cuoco, M.S., Rodman, C., Su, M.J., et al., A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade, Cell, 2018, vol. 175, no. 4, pp. 984–997. https://doi.org/10.1016/j.cell.2018.09.006
Jiang, D.J., Jia, S.J., Dai, Z., and Li, Y.J., Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells, J. Mol. Cell. Cardiol., 2006, vol. 40, no. 4, pp. 529–539. https://doi.org/10.1016/j.yjmcc.2006.01.021
Jin, X., Mo, Q., Zhang, Y., Gao, Y., Wu, Y., et al., The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer, Cancer Biol. Ther., 2016, vol. 17, no. 5, pp. 566–576. https://doi.org/10.1080/15384047.2016.1177676
Kapranos, N., Kominea, A., Konstantinopoulos, P., Savva, S., Artelaris, S., et al., Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance, Journal of Cancer Research and Clinical Oncology, 2002, vol. 128, no. 8, pp. 426–32. https://doi.org/10.1007/s00432-002-0357-y
Khandia, R., Munjal, A.K., Iqbal, H.M.N., and Dhama, K., Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders, Recent Patents on Inflammation & Allergy Drug Discovery, 2016. https://doi.org/10.2174/1872213x10666161213163301
Kim, T.W., Michniewicz, M., Bergmann, D.C., and Wang, Z.Y., Brassinosteroid regulates stomatal development by GSK3-mediated inhibition of a MAPK pathway, Nature, 2012. https://doi.org/10.1038/nature10794
Kuramitsu, Y., Wang, Y., Taba, K., Suenaga, S., Ryozawa, S., et al., Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells, Anticancer Res., 2012, vol. 32, no. 6, pp. 2295–2299.
Liu, Y., Gray, N.S., Rational design of inhibitors that bind to inactive kinase conformations, Nat. Chem. Biol., 2006, vol. 2, no. 7, pp. 358–364. https://doi.org/10.1038/nchembio799
Moens, U. and Kostenko, S., Structure and function of MK5/PRAK: the loner among the mitogen-activated protein kinase-activated protein kinases, Biol. Chem., 2013, vol. 394, no. 9, pp. 1115–1132. https://doi.org/10.1515/hsz-2013-0149
Önay Uçar, E. and Sengelen, A., Resveratrol and siRNA in combination reduces Hsp27 expression and induces caspase-3 activity in human glioblastoma cells, Cell Stress Chaperones, 2019, vol. 24, no. 4, pp. 763–775. https://doi.org/10.1007/s12192-019-01004-z
Pargellis, C., Tong, L., Churchill, L., Cirillo, P.F., Gilmore, T., et al., Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site, Nat. Struct. Biol., 2002, vol. 9, pp. 268–272. https://doi.org/10.1038/nsb770
Parsons, D.W., Jones, S., Zhang, X., Lin, J.C.H., Leary, R.J., et al., An integrated genomic analysis of human glioblastoma multiforme, Science, 2008, vol. 321, no. 5897, pp. 1807–1812. https://doi.org/10.1126/science.1164382
Pavan, S., Musiani, D., Torchiaro, E., Migliardi, G., Gai, M., et al., HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor, Int. J. Cancer, 2014, vol. 134, pp. 1289–1299. https://doi.org/10.1002/ijc.28464
Peregrin, S., Jurado-Pueyo, M., Campos, P.M., Sanz-Moreno, V., Ruiz-Gomez, A., et al., Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK, Curr. Biol., 2006, vol. 16, no. 20, pp. 2042–2047. https://doi.org/10.1016/j.cub.2006.08.083
Rocchi, P., So, A., Kojima, S., Signaevsky, M., Beraldi, E., et al., Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer, Cancer Res., 2004, vol. 64, no. 18, pp. 6595–6602. https://doi.org/10.1158/0008-5472
Sahin, Z., Ertas, M., Berk, B., Biltekin, S.N., Yurttas, L., and Demirayak, S., Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl) thiazole derivatives, Bioorg. Med. Chem., 2018, vol. 26, no. 8, pp. 1986–1995. https://doi.org/10.1016/j.bmc.2018.02.048
Sakai, A., Otani, M., Miyamoto, A., Yoshida, H., Furuya, E., and Tanigawa, N., Identification of phosphorylated serine-15 and-82 residues of HSPB1 in 5-fluorouracil-resistant colorectal cancer cells by proteomics, J. Proteomics, 2012, vol. 75, no. 3, pp. 806–818. https://doi.org/10.1016/j.jprot.2011.09.023
Samali, A., Robertson, J.D., Peterson, E., Manero, F., van Zeijl, L. et al., Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli, Cell Stress Chaperones, 2001, vol. 6, no. 1, pp. 49–58. https://doi.org/10.1379/1466-1268(2001)006<0049:hpmotc>2.0.co;2
Sayama, K., Hanakawa, Y., Nagai, H., Shirakata, Y., Dai, X., et al., Transforming growth factor-β-activated kinase 1 is essential for differentiation and the prevention of apoptosis in epidermis, J. Biol. Chem., 2006. https://doi.org/10.1074/jbc.M601065200
Shah, S.P., Nooka, A.K., Jaye, D.L., Bahlis, N.J., Lonial, S., and Boise, L.H., Bortezomib-induced heat shock response protects multiple myeloma cells and is activated by heat shock factor 1 serine 326 phosphorylation, Oncotarget, 2016, vol. 7, no. 37, p. 59727. https://doi.org/10.18632/oncotarget.10847
Taba, K., Kuramitsu, Y., Ryozawa, S., Yoshida, K., Tanaka, T., et al., Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells, Anticancer Research, 2010, vol. 30, no. 7, pp. 2539–2543.
Takeda, K. and Ichijo, H., Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system, Genes Cells, 2002, vol. 7, no. 11, pp. 1099–1111. https://doi.org/10.1046/j.1365-2443.2002.00591.x
Uçar, E.Ö., Arda, N., and Aitken, A., Extract from mistletoe, Viscum album L., reduces Hsp27 and 14-3-3 protein expression and induces apoptosis in C6 rat glioma cells, Genet. Mol. Res., 2012, vol. 11, no. 3, pp. 2801–2813. https://doi.org/10.4238/2012.August.24.5
Venkatakrishnan, C.D., Dunsmore, K., Wong, H., Roy, S., Sen, C.K., et al., HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest, Am. J. Physiol.: Heart Circ. Physiol., 2008, vol. 294, no. 4, pp. 1736–1744. https://doi.org/10.1152/ajpheart.91507.2007
Wang, H.Q., Yang, B., Xu, C.L., Wang, L.H., Zhang, Y.X., et al., Differential phosphoprotein levels and pathway analysis identify the transition mechanism of LNCaP cells into androgen-independent cells, Prostate, 2010, vol. 70, no. 5, pp. 508–517. https://doi.org/10.1002/pros.21085
Xu, F., Yang, T., Fang, D., Xu, Q., and Chen, Y., An investigation of heat shock protein 27 and P glycoprotein mediated multi-drug resistance in breast cancer using liquid chromatography-tandem mass spectrometry-based targeted proteomics, J. Proteomics, 2014, vol. 108, pp. 188–197. https://doi.org/10.1016/j.jprot.2014.05.016
Yasui, H., Hideshima, T., Ikeda, H., Jin, J., Ocio, E.M., et al., BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth, Br. J. Haematol., 2007, vol. 136, no. 3, pp. 414–423. https://doi.org/10.1111/j.1365-2141.2006.06443.x
Zhao, L., Wang, Y., Xu, Y., Sun, Q., Liu, H., et al., BIRB796, an inhibitor of p38 mitogen-activated protein kinase, ınhibits proliferation and ınvasion in glioblastoma cells, ACS Omega., 2021, vol. 6, no. 17, pp. 11466–11473. https://doi.org/10.1021/acsomega.1c00521
Zhu, J., Wang, J., Huang, J., Du, W., He, Y., et al., MicroRNA‑140‑5p regulates the proliferation, apoptosis and inflammation of RA FLSs by repressing STAT3, Exp. Ther. Med., 2021, vol. 21, no. 2, pp. 1–1. https://doi.org/10.3892/etm.2020.9602
ACKNOWLEDGMENTS
The authors gratefully acknowledge the financial support of the University.
Funding
This work was supported by the Istanbul University Research Foundation, Turkey (Project no. 24496).
Author information
Authors and Affiliations
Contributions
SNB made the conception, design and performed the experiments. EÖU provided the development of methodology, and financial support. SNB wrote the manuscript. EÖU revised the manuscript. All authors read and approved the fnal manuscript.
Corresponding author
Ethics declarations
The authors declare no conficts of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Sevde Nur Biltekin, Evren Önay Uçar Separate and Mutual Effects of BIRB796 and Bortezomib on pHsp27 and Viability of U87MG Glioma Cells. Biol Bull Russ Acad Sci 50, 761–772 (2023). https://doi.org/10.1134/S1062359023600976
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1062359023600976